Indian Central Drugs Standard Control Organization
GPTKB entity
Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
regulatory agency
|
| gptkbp:approves |
new drugs
|
| gptkbp:collaboratesWith |
gptkb:World_Health_Organization
academic institutions |
| gptkbp:conducts |
training programs
workshops and seminars inspections post-marketing surveillance |
| gptkbp:coordinatesWith |
state drug control authorities
|
| gptkbp:develops |
standards for drug testing
national drug policy |
| gptkbp:engagesIn |
public awareness campaigns
|
| gptkbp:ensures |
drug safety
compliance with international standards quality control of drugs |
| gptkbp:establishedIn |
1966
|
| gptkbp:facilitates |
stakeholder engagement
public consultations |
| gptkbp:handles |
import and export of drugs
|
| https://www.w3.org/2000/01/rdf-schema#label |
Indian Central Drugs Standard Control Organization
|
| gptkbp:issues |
annual reports
guidelines for clinical trials public health advisories drug licenses recalls for unsafe drugs certificates of pharmaceutical product guidelines for drug pricing notifications for drug shortages |
| gptkbp:locatedIn |
gptkb:India
|
| gptkbp:maintains |
drug database
|
| gptkbp:monitors |
adverse drug reactions
drug market trends |
| gptkbp:operates |
gptkb:Ministry_of_Health_and_Family_Welfare
|
| gptkbp:oversees |
clinical trials
|
| gptkbp:participatesIn |
international drug regulatory forums
|
| gptkbp:promotes |
pharmacovigilance
innovation in drug development rational use of drugs |
| gptkbp:provides |
technical support
advisory services information on drug safety guidelines for drug manufacturing data for health policy making support for drug regulatory capacity building technical guidance for drug registration |
| gptkbp:publishes |
drug regulations
|
| gptkbp:regulates |
medical devices
cosmetics pharmaceutical industry |
| gptkbp:responsibleFor |
drug approval
|
| gptkbp:reviews |
clinical trial applications
|
| gptkbp:supports |
research and development
healthcare_initiatives |